Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Plavix launched in Japan

May 10, 2006

New coagulation factor Xa inhibitors emerge from Bristol-Myers Squibb R&D

May 10, 2006

Heparins interfere with P-selectin binding and block metastasis

May 9, 2006

Novel antiatherothrombotic drug shows promise in preclinical studies

May 5, 2006

Oral direct thrombin inhibitor MPC-0920 begins phase I study

May 4, 2006

New treatment options reported for disorders associated with blood coagulation

May 3, 2006

New phase II trial to evaluate INS-50589 Antiplatelet in CABG patients

May 2, 2006

Coagulation factor Xa inhibitors prepared and tested at Merck

April 27, 2006

New anticoagulant agents emerge from sanofi-aventis R&D

April 20, 2006

Fast track status for thrombin receptor antagonist SCH-530348

April 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....